FDA approves AstraZeneca’s baxdrostat for certain patients with hypertensionnews2026-05-18T10:01:41+00:00May 18th, 2026|Endpoints News|
Makary resigns; Biogen reports Alzheimer’s data; and morenews2026-05-16T10:00:39+00:00May 16th, 2026|Endpoints News|
CDER chief Høeg fired from FDA as other top roles turn overnews2026-05-15T20:27:01+00:00May 15th, 2026|Endpoints News|
Biopharma M&A maintains strength even as large deals wanenews2026-05-15T17:56:32+00:00May 15th, 2026|Endpoints News|
Amgen expands crackdown on what it says is misuse of 340B programnews2026-05-15T17:31:40+00:00May 15th, 2026|Endpoints News|
Candel reports prostate cancer drug’s long-term data ahead of FDA filingnews2026-05-15T15:30:00+00:00May 15th, 2026|Endpoints News|
Post-Hoc Live: Makary’s out at FDA and what comes nextnews2026-05-15T15:21:51+00:00May 15th, 2026|Endpoints News|
Aardvark’s next move after clinical hold; Alumis’ verdict on Acelyrin assetnews2026-05-15T14:22:19+00:00May 15th, 2026|Endpoints News|
M&A isn’t just for big pharma. Mid-size companies are stepping up deal huntsnews2026-05-15T12:43:17+00:00May 15th, 2026|Endpoints News|
Andrea Pfeifer ends 23-year reign at AC Immune; Acadia’s top R&D exec announces retirementnews2026-05-15T11:00:01+00:00May 15th, 2026|Endpoints News|
